Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database.

French national health insurance database infectious diseases multiple myeloma pharmacoepidemiology vaccines

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
02 Dec 2020
Historique:
received: 21 10 2020
revised: 23 11 2020
accepted: 29 11 2020
entrez: 5 12 2020
pubmed: 6 12 2020
medline: 6 12 2020
Statut: epublish

Résumé

Infections are frequent and often result in serious complications in patients with multiple myeloma (MM). Prophylactic vaccination is recommended for influenza virus, MM patients were selected through the French national health insurance database from 1 January 2010 to 31 December 2015. Patients with a previous history of MM were excluded. Vaccination rates against influenza, The low rates of vaccination indicate the need to improve physician and MM patient adherence and education regarding vaccination.

Identifiants

pubmed: 33276450
pii: vaccines8040722
doi: 10.3390/vaccines8040722
pmc: PMC7712872
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-11-PHUC-001

Références

Rev Med Interne. 2015 Jun;36(6):411-7
pubmed: 25547954
Leukemia. 2014 May;28(5):981-92
pubmed: 24177258
Eur J Haematol. 1998 Aug;61(2):140-4
pubmed: 9714528
Br J Haematol. 2007 Sep;138(5):563-79
pubmed: 17686051
N Engl J Med. 2004 Oct 28;351(18):1860-73
pubmed: 15509819
Heliyon. 2017 Nov 06;3(11):e00441
pubmed: 29159320
Mayo Clin Proc. 2002 Aug;77(8):813-22
pubmed: 12173715
Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):495-502
pubmed: 27364264
Leukemia. 2018 Jul;32(7):1542-1560
pubmed: 29720735
Clin Vaccine Immunol. 2011 Jun;18(6):969-77
pubmed: 21508164
Medicine (Baltimore). 2017 Mar;96(12):e6189
pubmed: 28328805
Support Care Cancer. 2016 Nov;24(11):4791-9
pubmed: 27435321
Haematologica. 2015 Jan;100(1):107-13
pubmed: 25344526
Br J Cancer. 2000 Apr;82(7):1261-5
pubmed: 10755398
BMC Public Health. 2009 Jan 22;9:33
pubmed: 19161613
Am J Hematol. 2015 Apr;90(4):301-5
pubmed: 25557586
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Blood Rev. 2013 May;27(3):133-42
pubmed: 23623929
Hum Vaccin. 2008 Jul-Aug;4(4):309-12
pubmed: 18398302
Haematologica. 2012 Jun;97(6):854-8
pubmed: 22180421
Med Care. 2016 Feb;54(2):188-94
pubmed: 26683778
Therapie. 2014 Sep-Oct;69(5):437-48
pubmed: 25285364
J Clin Oncol. 2007 May 20;25(15):1993-9
pubmed: 17420512
Leukemia. 2014 May;28(5):1122-8
pubmed: 24157580
J Patient Cent Res Rev. 2017 Apr 25;4(2):53-59
pubmed: 31413971
Clin Infect Dis. 2009 Oct 15;49(8):1211-25
pubmed: 19769539
J Clin Pathol. 1995 Mar;48(3):260-6
pubmed: 7730490
Blood. 2014 Nov 20;124(22):3308-15
pubmed: 25305203
Leukemia. 2014 Jun;28(6):1346-8
pubmed: 24418994

Auteurs

Guilhem Tournaire (G)

Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.

Cécile Conte (C)

Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
UMR1027, Inserm, Université Paul Sabatier, 31330 Toulouse, France.
Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Université Paul Sabatier, 31000 Toulouse, France.
Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.

Aurore Perrot (A)

Département d'Hématologie et de médecine Interne, Institut Universitaire du Cancer-Oncopole, CHU de Toulouse, 31000 Toulouse, France.

Maryse Lapeyre-Mester (M)

Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
UMR1027, Inserm, Université Paul Sabatier, 31330 Toulouse, France.
Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Université Paul Sabatier, 31000 Toulouse, France.
Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.
INSERM Centre d'Investigation Clinique 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.

Fabien Despas (F)

Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
UMR1027, Inserm, Université Paul Sabatier, 31330 Toulouse, France.
Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Université Paul Sabatier, 31000 Toulouse, France.
Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.
INSERM Centre d'Investigation Clinique 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.

Classifications MeSH